Dispute over Capricorn proposed merger
Capricorn prepares for February showdown
The firm’s board continues to push back against opposition among some shareholders to plans for a merger with Israeli independent New Med
The dispute between London-listed Capricorn Energy’s board and shareholders over the proposed merger with Israel’s New Med is likely to come to a head in early February, with an extraordinary general meeting planned for the first of the month. The board expects to hold a “vote on the combination on or around the same date”. The shareholder revolt is being led by London-based fund Palliser Capital, which owns 6.96pc of Capricorn shares but claims that shareholders representing more than 40pc “disapprove of the New Med deal”. The fund called for a general meeting back in December, stating that it, “as required by the articles [of incorporation]... must take place by 30 January 2023 at the late
Also in this section
1 April 2026
Golden Pass’s startup offers QatarEnergy a timely boost but may also force a difficult choice between honouring disrupted contracts and capitalising on soaring spot LNG prices
1 April 2026
It is not a case of if or when, but the length and magnitude of economic damage from elevated oil prices
1 April 2026
The US-Iran conflict demonstrates the need for diversification in several senses of the word. It also exposes the limits of Washington applying pressure on major oil and gas producers it considers geopolitical adversaries
31 March 2026
Disappointing results in its bidding round are a reality check for Libya, and global exploration generally
